Global Oncology Drugs Industry 2013-2018 Trend, Profit, And Forecast Analysis

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

The global oncology drugs industry experienced significant growth during the past five years and is expected to continue that momentum to reach an estimated $100.6 billion in 2018.

Lucintel, a leading global management consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in “Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs.

Lucintel’s study of the oncology drugs industry includes all classes of drugs that are used as an anti-cancer drug for the treatment of cancer such as lung cancer, mouth cancer, colorectal cancer, skin cancer, kidney cancer, and all such other types of cancer, which are marketed and distributed as an oncology drugs. http://www.bharatbook.com/healthcare-market-research-reports/global-oncology-drugs-industry-2013-2018-trend-profit-and-forecast-analysis.html

North America dominates this industry with more than one-third of the market share. Roche Holding Ltd., Novartis AG, Astra Zeneca ...
... Plc, Eli Lilly & Co., and Sanofi SA are the major industry players. A combination of factors such as technology innovations, medical insurance coverage, aging population, and changing lifestyles are seen to affect market dynamics significantly. The industry has seen a number of recent changes including growing competition, rise in merger and acquisition activities, increased cancer health insurance coverage, and an increasing amount of foreign direct investment.

As per the study, aging population, changing lifestyles, more effective diagnosing, unhealthy eating habits, and an increasing incidence of chronic diseases across the entire global population will provide growth opportunities for the oncology drugs industry players.

This study provides an overview of the global oncology drugs industry and tracks industry performance in four geographic regions. The report studies manufacturers and distributors of oncology drugs, providing a five-year annual trend analysis that highlights market size, profit and cost structure for North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). The report also provides a forecast, addressing market opportunities for next five years for each of these regions.

This comprehensive guide from Lucintel provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global oncology drugs industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.

To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:

• Industry size estimates in terms of (US $) value by regions
• Global oncology drugs industry analysis annual trend (2007-2012) and forecast (2013-2018)
• Porter’s Five Force analysis
• New product launch and merger and acquisition activity in global oncology drugs industry analysis
• Quarterly demand trend (Q1 2011-Q4 2012) and forecast analysis (Q1 2013-Q4 2014) for global oncology drugs industry analysis
• Gross and net profit trends in the global oncology drugs industry analysis
• Cost structure trend in the global as well as regional oncology drugs analysis
• More than 48 valuable figures/charts and 12 tables are provided in this report

Table of Contents
1. Executive Summary
2. Industry Definition and Scope
3. Industry Overview
4. Global Macroeconomic Overview
5. Industry Trends
6. Industry Forecasts
7. Emerging Trends
8. Conclusions

For more information kindly visit :
http://www.bharatbook.com/healthcare-market-research-reports/global-oncology-drugs-industry-2013-2018-trend-profit-and-forecast-analysis.html

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/researchbook
Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/